Posts Tagged ‘covid19’

Lamont Hints At When Coronavirus Restrictions Could Kick In | Across Connecticut, CT Patch

December 8, 2020

https://patch.com/connecticut/across-ct/lamont-hints-when-coronavirus-restrictions-could-kick

The Coronavirus Won’t Stop Evolving When the Vaccine Arrives – The New York Times

December 6, 2020

The Coronavirus Won’t Stop Evolving When the Vaccine Arrives – The New York Times

https://www.nytimes.com/2020/11/27/science/covid-vaccine-virus-resistance.html

Did Pangolin Trafficking Cause the Coronavirus Pandemic? | The New Yorker

December 4, 2020

https://www.newyorker.com/magazine/2020/08/31/did-pangolins-start-the-coronavirus-pandemic

The ethical questions that haunt facial-recognition research

December 3, 2020

https://www.nature.com/articles/d41586-020-03187-3
Thought a lot of the issues discussed in this article were potentially applicable to genomics

Covid mutation

November 30, 2020

D614G mutation

https://www.nytimes.com/2020/11/24/world/covid-mutation.html

Evidence Builds That an Early Mutation Made the Pandemic Harder to Stop

Scientists were initially skeptical that a mutation made the coronavirus more contagious. But new research has changed many of their minds.

Eli Lilly’s Antibody Treatment Gets Emergency F.D.A. Approval – The New York Times

November 25, 2020

https://www.nytimes.com/live/2020/11/09/world/covid-19-coronavirus-live-updates QT:{{”

The Food and Drug Administration has granted emergency authorization of a Covid-19 treatment made by the American pharmaceutical company Eli Lilly that was given to Chris Christie, the former New Jersey governor, when he was infected with the coronavirus.

The authorization, announced on Monday, applies only to people newly infected with the virus, and the agency said it should not be used in hospitalized patients. The treatment is approved for people 12 and older who have tested positive and are at risk for developing a severe form of Covid-19 or being hospitalized for the condition. That includes people who are over 65 and obese, the agency said — a key group that early studies have shown can benefit the most from the treatment.

Eli Lilly said that its treatment, called bamlanivimab, should be administered as soon as possible after a positive test, and within 10 days of developing symptoms.
“}}

bamlanivimab

Is facial recognition too biased to be let loose?

November 22, 2020

https://www.nature.com/articles/d41586-020-03186-4

The ethical questions that haunt facial-recognition research

November 22, 2020

https://www.nature.com/articles/d41586-020-03187-3

Resisting the rise of facial recognition

November 22, 2020

https://www.nature.com/articles/d41586-020-03188-2

Why do COVID death rates seem to be falling?

November 22, 2020

https://www.nature.com/articles/d41586-020-03132-4